iBio price target cut to $5.53
A FactSet-sourced analyst action set iBio’s 12-month price target to $5.53, implying 447% upside versus the current reference.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
A FactSet-sourced analyst action set iBio’s 12-month price target to $5.53, implying 447% upside versus the current reference.